Evidence map›Paper›PMID 12629067›Full record

ArticleThe Journal of experimental medicine2003

Preferential accumulation of antigen-specific effector CD4 T cells at an antigen injection site involves CD62E-dependent migration but not local proliferation.

R Lee Reinhardt, Daniel C Bullard, Casey T Weaver, Marc K Jenkins

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 144 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Co-delivery of autoantigen and dexamethasone in incomplete Freund's adjuvant ameliorates experimental autoimmune encephalomyelitis.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Article
  8. Review
  9. Article
  10. Review
  11. Regulatory T cell memory.Nature reviews. Immunology · 2016
    Review
  12. Adjuvants for peptide-based cancer vaccines.Journal for immunotherapy of cancer · 2016
    Review
  13. Review
  14. Article
  15. Cancer vaccines: Trafficking of tumor-specific T cells to tumor after therapeutic vaccination.The international journal of biochemistry & cell biology · 2014
    Review
  16. Article
  17. Article
  18. Review
  19. CD4 T-cell memory generation and maintenance.Critical reviews in immunology · 2014
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

R Lee ReinhardtDepartment of Microbiology and the Center for Immunology, University of Minnesota, Minneapolis, MN 55455, USA.
Daniel C Bullard
Casey T Weaver
Marc K Jenkins
University of Alabama at Birmingham · USUniversity of Minnesota · US

Funding

Type I interferons in tolerance in the steady stateP01AI035296 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI JENKINS, MARC KEVIN · 1993 to 2023
$31.1M
TRACKING CD4+ MEMORY T CELLS IN VIVOR01AI039614 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI JENKINS, MARC KEVIN · 1996 to 2023
$8.7M
IMMUNOLOGY TRAINING PROGRAMT32AI007313 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Carla Rothlin · 1989 to 2026
$5.7M
COSTIMULATORY SIGNALS IN CD4+ T-CELL ACTIVATIONR01AI027998 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI JENKINS, MARC KEVIN · 1989 to 2022
$4.5M
Costimulatory Signals in CD4+ T Cell ActivationR37AI027998 · NIAID · UNIVERSITY OF MINNESOTA · PI JENKINS, MARC KEVIN · 2008 to 2017
$3.7M
POSTTHYMIC T-CELL FUNCTIONAL REPERTOIRE HETEROGENEITYR01AI035783 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WEAVER, CASEY T · 1994 to 2010
$2.4M
POSTTHYMIC T CELL FUNCTIONAL REPERTOIRE HETEROGENEITYR21AI035783 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WEAVER, CASEY T · 1997 to 2003
$363k
ROLE OF THE SELECTIONS IN THE DEVELOPMENT OF VASCULITISR03AR046404 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BULLARD, DANIEL C · 1999 to 2001
$144k
NIAID NIH HHS AI13578NIAID NIH HHS AI27998NIAID NIH HHS AI35296NIAID NIH HHS AI39614NIAID NIH HHS P01 AI035296NIAID NIH HHS R01 AI027998NIAID NIH HHS R01 AI035783NIAID NIH HHS R01 AI039614NIAID NIH HHS R21 AI035783NIAID NIH HHS R37 AI027998NIAID NIH HHS T32 AI007313NIAMS NIH HHS AR46404
6 · The paper itself

Abstract

The migration of antigen-specific T cells to nonlymphoid tissues is thought to be important for the elimination of foreign antigens from the body. However, recent results showing the migration of activated T cells into many nonlymphoid tissues raised the possibility that antigen-specific T cells do not migrate preferentially to nonlymphoid tissues containing antigen. We addressed this question by tracking antigen-specific CD4 T cells in the whole body after a localized subcutaneous antigen injection. Antigen-specific CD4 T cells proliferated in the skin-draining lymph nodes and the cells that underwent the most cell divisions acquired the ability to bind to CD62P. As time passed, CD62P-binding antigen-specific CD4 T cells with interferon gamma production potential accumulated preferentially at the site of antigen injection but only in recipients that expressed CD62E. Surprisingly, these T cells did not proliferate in the injection site despite showing evidence of more cell divisions than the T cells in the draining lymph nodes. The results suggest that the most divided effector CD4 T cells from the lymph nodes enter the site of antigen deposition via recognition of CD62E on blood vessels and are retained there in a nonproliferative state via recognition of peptide-major histocompatibility complex II molecules.

Indexed as

Adoptive TransferAnimalsAntigensAntimetabolitesBromodeoxyuridineCD4-Positive T-LymphocytesCell DivisionCell MovementE-SelectinImmunizationImmunohistochemistryInterferon-gammaInterleukin-2MiceMice, Inbred StrainsOvalbuminAntigensAntimetabolitesBromodeoxyuridineE-SelectinInterferon-gammaInterleukin-2Ovalbumin

Identifiers

PMID12629067
PMCPMC2193845
OpenAlexW2168822664

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.